Lenalidomide-6-F is primarily utilized in the field of pharmaceutical research and development, particularly in the study of cancer therapies. It serves as a key intermediate in the synthesis of lenalidomide derivatives, which are known for their potent anti-cancer properties. These derivatives are extensively investigated for their efficacy in treating multiple myeloma and myelodysplastic syndromes. The compound is also employed in the development of targeted therapies that aim to modulate the immune system and inhibit the proliferation of malignant cells. Additionally, Lenalidomide-6-F is used in preclinical studies to explore its potential in combination therapies, enhancing the effectiveness of existing treatments and reducing drug resistance in cancer patients.